Methionine sulfoxide reductase (Msr) dysfunction in human brain disease

References

• Hancock JT. Harnessing evolutionary toxins for signaling: reactive oxygen species, nitric oxide and hydrogen sulfide in plant cell regulation. Front Plant Sci. 2017;8:189.
   PubMed Web of Science ®Google Scholar
• Buffenstein R, Edrey YH, Yang T, et al. The oxidative stress theory of aging: embattled or invincible? Insights from non-traditional model organisms. Age. 2008;30(2–3):99–109.
   PubMedGoogle Scholar
• Moskovitz J, Berlett BS, Poston JM, et al. The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. Proc Natl Acad Sci USA. 1997;94(18):9585–9589.
   PubMed Web of Science ®Google Scholar
• Schild L, Reiser G. Oxidative stress is involved in the permeabilization of the inner membrane of brain mitochondria exposed to hypoxia/reoxygenation and low micromolar Ca2+. FEBS J. 2005;272(14):3593–3601.
   PubMed Web of Science ®Google Scholar
• Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr. 2000;72(2 Suppl):653S–669S.
   PubMed Web of Science ®Google Scholar
• Sauer H, Wartenberg M. Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxid Redox Signal. 2005;7(11–12):1423–1434.
   PubMed Web of Science ®Google Scholar
• Tappia PS, Dent MR, Dhalla NS. Oxidative stress and redox regulation of phospholipase D in myocardial disease. Free Radic Biol Med. 2006;41(3):349–361.
   PubMed Web of Science ®Google Scholar
• West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol. 2011;11(6):389–402.
   PubMed Web of Science ®Google Scholar
• Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82(1):47–95.
   PubMed Web of Science ®Google Scholar
• Schallreuter KU, Rübsam K, Chavan B, et al. Functioning methionine sulfoxide reductases A and B are present in human epidermal melanocytes in the cytosol and in the nucleus. Biochem Biophys Res Commun. 2006;342(1):145–152.
   PubMed Web of Science ®Google Scholar
• Gabbita SP, Aksenov MY, Lovell MA, et al. Decrease in peptide methionine sulfoxide reductase in Alzheimer’s disease brain. J Neurochem. 1999;73(4):1660–1666.
   PubMed Web of Science ®Google Scholar
• Markesbery WR, Carney JM. Oxidative alterations in Alzheimer’s disease. Brain Pathol. 1999;9(1):133–146.
   PubMed Web of Science ®Google Scholar
• Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000;290(5493):985–989.
   PubMed Web of Science ®Google Scholar
• Oien D, Moskovitz J. Protein-carbonyl accumulation in the non-replicative senescence of the methionine sulfoxide reductase A (msrA) knockout yeast strain. Amino Acids. 2007;32(4):603–606.
   PubMed Web of Science ®Google Scholar
• Kim HY, Gladyshev VN. Characterization of mouse endoplasmic reticulum methionine-R-sulfoxide reductase. Biochem Biophys Res Commun. 2004;320(4):1277–1283.
   PubMed Web of Science ®Google Scholar
• Weissbach H, Etienne F, Hoshi T, et al. Peptide methionine sulfoxide reductase: structure, mechanism of action, and biological function. Arch Biochem Biophys. 2002;397(2):172–178.
   PubMed Web of Science ®Google Scholar
• Delaye L, Becerra A, Orgel L, et al. Molecular evolution of peptide methionine sulfoxide reductases (MsrA and MsrB): on the early development of a mechanism that protects against oxidative damage. J Mol Evol. 2007;64(1):15–32.
   PubMed Web of Science ®Google Scholar
• Lee BC, Lee YK, Lee HJ, et al. Cloning and characterization of antioxidant enzyme methionine sulfoxide-S-reductase from Caenorhabditis elegans. Arch Biochem Biophys. 2005;434(2):275–281.
   PubMed Web of Science ®Google Scholar
• Levine RL, Mosoni L, Berlett BS, et al. Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA. 1996;93(26):15036–15040.
   PubMed Web of Science ®Google Scholar
• Gao F, Yi J, Shi GY, et al. The susceptibility of leukemia cells to arsenic trioxide-induced apoptosis is determined by cellular reactive oxygen species level. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao. 2001;33(5):585–589.
   PubMedGoogle Scholar
• Jung S, Hansel A, Kasperczyk H, et al. Activity, tissue distribution and site-directed mutagenesis of a human peptide methionine sulfoxide reductase of type B: hCBS1. FEBS Lett. 2002;527(1–3):91–94.
   PubMed Web of Science ®Google Scholar
• Kryukov GV, Kumar RA, Koc A, et al. Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide reductase. Proc Natl Acad Sci USA. 2002;99(7):4245–4250.
   PubMed Web of Science ®Google Scholar
• Kumar RA, Koc A, Cerny RL, et al. Reaction mechanism, evolutionary analysis, and role of zinc in Drosophila methionine-R-sulfoxide reductase. J Biol Chem. 2002;277(40):37527–37535.
   PubMed Web of Science ®Google Scholar
• Moskovitz J, Jenkins NA, Gilbert DJ, et al. Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc Natl Acad Sci USA. 1996;93(8):3205–3208.
   PubMed Web of Science ®Google Scholar
• Lein ES, Hawrylycz MJ, Ao N, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007;445(7124):168–176.
   PubMed Web of Science ®Google Scholar
• Ruan H, Tang XD, Chen ML, et al. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA. 2002;99(5):2748–2753.
   PubMed Web of Science ®Google Scholar
• Moskovitz J, Flescher E, Berlett BS, et al. Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc Natl Acad Sci USA. 1998;95(24):14071–14075.
   PubMed Web of Science ®Google Scholar
• Moskovitz J, Bar-Noy S, Williams WM, et al. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA. 2001;98(23):12920–12925.
   PubMed Web of Science ®Google Scholar
• Prentice HM, Moench IA, Rickaway ZT, et al. MsrA protects cardiac myocytes against hypoxia/reoxygenation induced cell death. Biochem Biophys Res Commun. 2008;366(3):775–778.
   PubMed Web of Science ®Google Scholar
• Yermolaieva O, Xu R, Schinstock C, et al. Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation. Proc Natl Acad Sci USA. 2004;101(5):1159–1164.
   PubMed Web of Science ®Google Scholar
• Kantorow M, Hawse JR, Cowell TL, et al. Methionine sulfoxide reductase A is important for lens cell viability and resistance to oxidative stress. Proc Natl Acad Sci USA. 2004;101(26):9654–9659.
   PubMed Web of Science ®Google Scholar
• Picot CR, Petropoulos I, Perichon M, et al. Overexpression of MsrA protects WI-38 SV40 human fibroblasts against H2O2-mediated oxidative stress. Free Radic Biol Med. 2005;39(10):1332–1341.
   PubMed Web of Science ®Google Scholar
• Moskovitz J, Rahman MA, Strassman J, et al. Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage. J Bacteriol. 1995;177(3):502–507.
   PubMed Web of Science ®Google Scholar
• Nan C, Li Y, Jean-Charles PY, et al. Deficiency of methionine sulfoxide reductase A causes cellular dysfunction and mitochondrial damage in cardiac myocytes under physical and oxidative stresses. Biochem Biophys Res Commun. 2010;402(4):608–613.
   PubMed Web of Science ®Google Scholar
• Zhao H, Sun J, Deschamps AM, et al. Myristoylated methionine sulfoxide reductase A protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2011;301(4):H1513–H1518.
   PubMed Web of Science ®Google Scholar
• Gu SX, Blokhin IO, Wilson KM, et al. Protein methionine oxidation augments reperfusion injury in acute ischemic stroke. JCI Insight. 2016;1(7):4180.
   Web of Science ®Google Scholar
• Olry A, Boschi-Muller S, Marraud M, et al. Characterization of the methionine sulfoxide reductase activities of PILB, a probable virulence factor from Neisseria meningitidis. J Biol Chem. 2002;277(14):12016–12022.
   PubMed Web of Science ®Google Scholar
• Etienne F, Spector D, Brot N, et al. A methionine sulfoxide reductase in Escherichia coli that reduces the R enantiomer of methionine sulfoxide. Biochem Biophys Res Commun. 2003;300(2):378–382.
   PubMed Web of Science ®Google Scholar
• Kwak GH, Kim JR, Kim HY. Expression, subcellular localization, and antioxidant role of mammalian methionine sulfoxide reductases in Saccharomyces cerevisiae. BMB Rep. 2009;42(2):113–118.
   PubMed Web of Science ®Google Scholar
• Kim HY, Gladyshev VN. Methionine sulfoxide reduction in mammals: characterization of methionine-R-sulfoxide reductases. Mol Biol Cell. 2004;15(3):1055–1064.
   PubMed Web of Science ®Google Scholar
• Cabreiro F, Picot CR, Perichon M, et al. Overexpression of mitochondrial methionine sulfoxide reductase B2 protects leukemia cells from oxidative stress-induced cell death and protein damage. J Biol Chem. 2008;283(24):16673–16681.
   PubMed Web of Science ®Google Scholar
• Koc A, Gasch AP, Rutherford JC, et al. Methionine sulfoxide reductase regulation of yeast lifespan reveals reactive oxygen species-dependent and -independent components of aging. Proc Natl Acad Sci USA. 2004;101(21):7999–8004.
   PubMed Web of Science ®Google Scholar
• Shchedrina VA, Vorbrüggen G, Lee BC, et al. Overexpression of methionine-R-sulfoxide reductases has no influence on fruit fly aging. Mech Ageing Dev. 2009;130(7):429–443.
   PubMed Web of Science ®Google Scholar
• Shchedrina VA, Kabil H, Vorbruggen G, et al. Analyses of fruit flies that do not express selenoproteins or express the mouse selenoprotein, methionine sulfoxide reductase B1, reveal a role of selenoproteins in stress resistance. J Biol Chem. 2011;286(34):29449–29461.
   PubMed Web of Science ®Google Scholar
• Lim DH, Han JY, Kim JR, et al. Methionine sulfoxide reductase B in the endoplasmic reticulum is critical for stress resistance and aging in Drosophila. Biochem Biophys Res Commun. 2012;419(1):20–26.
   PubMed Web of Science ®Google Scholar
• Jiang B, Moskovitz J. The functions of the mammalian methionine sulfoxide reductase system and related diseases. Antioxidants. 2018;7(9):122.
   Web of Science ®Google Scholar
• Walss-Bass C, Soto-Bernardini MC, Johnson-Pais T, et al. Methionine sulfoxide reductase: a novel schizophrenia candidate gene. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(2):219–225.
   PubMed Web of Science ®Google Scholar
• Ma X, Deng W, Liu X, et al. A genome-wide association study for quantitative traits in schizophrenia in China. Genes Brain Behav. 2011;10(7):734–739.
   PubMed Web of Science ®Google Scholar
• Wang KS, Liu X, Zhang Q, et al. Genome-wide association analysis of age at onset in schizophrenia in a European-American sample. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(6):671–680.
   Google Scholar
• Richards AL, Jones L, Moskvina V, et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol Psychiatry. 2012;17(2):193–201.
   PubMed Web of Science ®Google Scholar
• Goes FS, McGrath J, Avramopoulos D, et al. Genome-wide association study of schizophrenia in Ashkenazi Jews. Am J Med Genet B Neuropsychiatr Genet. 2015;168(8):649–659.
   PubMed Web of Science ®Google Scholar
• Meda SA, Ruaño G, Windemuth A, et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proc Natl Acad Sci USA. 2014;111(19):E2066–E2075.
   PubMedGoogle Scholar
• Pardiñas AF, Holmans P, Pocklington AJ, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50(3):381–389.
   PubMed Web of Science ®Google Scholar
• Do KQ, Cabungcal JH, Frank A, et al. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009;19(2):220–230.
   PubMed Web of Science ®Google Scholar
• Howes OD, Kambeitz J, Kim E, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012;69(8):776–786.
   PubMed Web of Science ®Google Scholar
• Liu F, Hindupur J, Nguyen JL, et al. Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson’s disease-related insults. Free Radic Biol Med. 2008;45(3):242–255.
   PubMed Web of Science ®Google Scholar
• Oien DB, Osterhaus GL, Latif SA, et al. MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Radic Biol Med. 2008;45(2):193–200.
   PubMed Web of Science ®Google Scholar
• Moskovitz J, Walss-Bass C, Cruz DA, et al. Methionine sulfoxide reductase regulates brain catechol-O-methyl transferase activity. Int J Neuropsychopharmacol. 2014;17(10):1707–1713.
   PubMed Web of Science ®Google Scholar
• Oien DB, Ortiz AN, Rittel AG, et al. Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse. J Neurochem. 2010;114(1):51–61.
   PubMed Web of Science ®Google Scholar
• Huttlin EL, Bruckner RJ, Paulo JA, et al. Architecture of the human interactome defines protein communities and disease networks. Nature. 2017;545(7655):505–509.
   PubMed Web of Science ®Google Scholar
• Moskovitz J, Walss-Bass C, Cruz DA, et al. The enzymatic activities of brain catechol-O-methyltransferase (COMT) and methionine sulphoxide reductase are correlated in a COMT Val/Met allele-dependent fashion. Neuropathol Appl Neurobiol. 2015;41(7):941–951.
   PubMed Web of Science ®Google Scholar
• Ni P, Ma X, Lin Y, et al. Methionine sulfoxide reductase A (MsrA) associated with bipolar I disorder and executive functions in A Han Chinese population. J Affect Disord. 2015;184:235–238.
   PubMed Web of Science ®Google Scholar
• Day FR, Helgason H, Chasman DI, et al. Physical and neurobehavioral determinants of reproductive onset and success. Nat Genet. 2016;48(6):617–623.
   PubMed Web of Science ®Google Scholar
• Okbay A, Baselmans BML, De Neve JE, et al. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat Genet. 2016;48(6):624–633.
   PubMed Web of Science ®Google Scholar
• Lo MT, Hinds DA, Tung JY, et al. Genome-wide analyses for personality traits identify six genomic loci and show correlations with psychiatric disorders. Nat Genet. 2017;49(1):152–156.
   PubMed Web of Science ®Google Scholar
• Fan Q, Wang W, Hao J, et al. Integrating genome-wide association study and expression quantitative trait loci data identifies multiple genes and gene set associated with neuroticism. Prog Neuropsychopharmacol Biol Psychiatry. 2017;78:149–152.
   PubMed Web of Science ®Google Scholar
• Boutwell B, Hinds D, 23AndMe Research Team, et al. Replication and characterization of CADM2 and MSRA genes on human behavior. Heliyon. 2017;3(7):e00349.
   PubMed Web of Science ®Google Scholar
• Luciano M, Hagenaars SP, Davies G, et al. Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism. Nat Genet. 2018;50(1):6–11.
   PubMed Web of Science ®Google Scholar
• Nagel M, Jansen PR, Stringer S, et al. Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat Genet. 2018;50(7):920–927.
   PubMed Web of Science ®Google Scholar
• Grove J, Ripke S, Als TD, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51(3):431–444.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mantilla AJ, Moreno-De-Luca A, Ledbetter DH, et al. A cross-disorder method to identify novel candidate genes for developmental brain disorders. JAMA Psychiatry. 2016;73(3):275–283.
   PubMed Web of Science ®Google Scholar
• Glancy M, Barnicoat A, Vijeratnam R, et al. Transmitted duplication of 8p23.1-8p23.2 associated with speech delay, autism and learning difficulties. Eur J Hum Genet. 2009;17(1):37–43.
   PubMed Web of Science ®Google Scholar
• Bosch N, Morell M, Ponsa I, et al. Nucleotide, cytogenetic and expression impact of the human chromosome 8p23.1 inversion polymorphism. PLoS One. 2009;4(12):e8269.
   PubMed Web of Science ®Google Scholar
• Herbet M, Korga A, Gawrońska-Grzywacz M, et al. Chronic variable stress is responsible for lipid and DNA oxidative disorders and activation of oxidative stress response genes in the brain of rats. Oxid Med Cell Longev. 2017;2017:7313090.
   PubMed Web of Science ®Google Scholar
• Kuschel L, Hansel A, Schönherr R, et al. Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA). FEBS Lett. 1999;456(1):17–21.
   PubMed Web of Science ®Google Scholar
• McNeil TF. Perinatal risk factors and schizophrenia: selective review and methodological concerns. Epidemiol Rev. 1995;17(1):107–112.
   PubMed Web of Science ®Google Scholar
• Schmidt-Kastner R, van Os J, Esquivel G, et al. An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry. 2012;17(12):1194–1205.
   PubMed Web of Science ®Google Scholar
• Oien DB, Osterhaus GL, Lundquist BL, et al. Caloric restriction alleviates abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide reductase A knockout mouse. Neurosci Lett. 2010;468(1):38–41.
   PubMed Web of Science ®Google Scholar
• Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60(8):1119–1122.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001;81(2):741–766.
   PubMed Web of Science ®Google Scholar
• Roychaudhuri R, Yang M, Hoshi MM, et al. Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem. 2009;284(8):4749–4753.
   PubMed Web of Science ®Google Scholar
• Vogt W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med. 1995;18(1):93–105.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Bush AI. Alzheimer’s amyloid beta-peptide (1–42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol Aging. 2004;25(5):563–568.
   PubMed Web of Science ®Google Scholar
• Kuo YM, Kokjohn TA, Beach TG, et al. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer’s disease brains. J Biol Chem. 2001;276(16):12991–12998.
   PubMed Web of Science ®Google Scholar
• Näslund J, Schierhorn A, Hellman U, et al. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA. 1994;91(18):8378–8382.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Galvan V, Lange MB, et al. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic Biol Med. 2010;48(1):136–144.
   PubMed Web of Science ®Google Scholar
• Kramer PL, Xu H, Woltjer RL, et al. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging. 2011;32(12):2113–2122.
   PubMed Web of Science ®Google Scholar
• Ridha BH, Barnes J, Bartlett JW, et al. Tracking atrophy progression in familial Alzheimer’s disease: a serial MRI study. Lancet Neurol. 2006;5(10):828–834.
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Pfefferbaum A, Swan GE, et al. Heritability of hippocampal size in elderly twin men: equivalent influence from genes and environment. Hippocampus. 2001;11(6):754–762.
   PubMed Web of Science ®Google Scholar
• Bis JC, DeCarli C, Smith AV, et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet. 2012;44(5):545–551.
   PubMed Web of Science ®Google Scholar
• Pal R, Oien DB, Ersen FY, et al. Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain Res. 2007;180(4):765–774.
   PubMed Web of Science ®Google Scholar
• Sagher D, Brunell D, Brot N, et al. Selenocompounds can serve as oxidoreductants with the methionine sulfoxide reductase enzymes. J Biol Chem. 2006;281(42):31184–31187.
   PubMed Web of Science ®Google Scholar
• Kalmijn S, Launer LJ, Lindemans J, et al. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol. 1999;150(3):283–289.
   PubMed Web of Science ®Google Scholar
• Baba M, Nakajo S, Tu PH, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol. 1998;152(4):879–884.
   PubMed Web of Science ®Google Scholar
• Wakabayashi K, Tanji K, Mori F, et al. The Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology. 2007;27(5):494–506.
   PubMed Web of Science ®Google Scholar
• Takeda A, Mallory M, Sundsmo M, et al. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol. 1998;152(2):367–372.
   PubMed Web of Science ®Google Scholar
• Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson’s disease. Science. 2003;302(5646):841.
   PubMed Web of Science ®Google Scholar
• Lindersson E, Beedholm R, Højrup P, et al. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem. 2004;279(13):12924–12934.
   PubMed Web of Science ®Google Scholar
• Inden M, Kondo J-I, Kitamura Y, et al. Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats. J Pharmacol Sci. 2005;97(2):203–211.
   PubMed Web of Science ®Google Scholar
• Snyder H, Mensah K, Hsu C, et al. Beta-synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein. J Biol Chem. 2005;280(9):7562–7569.
   PubMed Web of Science ®Google Scholar
• Sawada H, Kohno R, Kihara T, et al. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. J Biol Chem. 2004;279(11):10710–10719.
   PubMed Web of Science ®Google Scholar
• Oien DB, Carrasco GA, Moskovitz J. Decreased phosphorylation and increased methionine oxidation of α-synuclein in the methionine sulfoxide reductase A knockout mouse. J Amino Acids. 2011;2011:721094.
   PubMedGoogle Scholar
• Oien DB, Shinogle HE, Moore DS, et al. Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells. J Mol Neurosci. 2009;39(3):323–332.
   PubMed Web of Science ®Google Scholar
• Wassef R, Haenold R, Hansel A, et al. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson’s-like symptoms. J Neurosci. 2007;27(47):12808–12816.
   PubMed Web of Science ®Google Scholar
• Martin B, Golden E, Egan JM, et al. Reduced energy intake: the secret to a long and healthy life? IBS J Sci. 2007;2(2):35–39.
   PubMedGoogle Scholar
• Rühlmann C, Wölk T, Blümel T, et al. Long-term caloric restriction in ApoE-deficient mice results in neuroprotection via FGF21-induced AMPK/mTOR pathway. Aging (Albany NY). 2016;8(11):2777–2789.
   PubMedGoogle Scholar
• Bayliss JA, Lemus MB, Stark R, et al. Ghrelin-AMPK signaling mediates the neuroprotective effects of calorie restriction in Parkinson’s disease. J Neurosci. 2016;36(10):3049–3063.
   PubMed Web of Science ®Google Scholar
• Lin AL, Zhang W, Gao X, et al. Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain. Neurobiol Aging. 2015;36(7):2296–2303.
   PubMed Web of Science ®Google Scholar
• Pani G. Neuroprotective effects of dietary restriction: evidence and mechanisms. Semin Cell Dev Biol. 2015;40:106–114.
   PubMed Web of Science ®Google Scholar
• Bille DS, Banasik K, Justesen JM, et al. Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult Danes. PLoS ONE. 2011;6(6):e20640.
   PubMed Web of Science ®Google Scholar
• Carey DG, Jenkins AB, Campbell LV, et al. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45(5):633–638.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761.
   PubMed Web of Science ®Google Scholar
• Fujita K, Nishizawa H, Funahashi T, et al. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J. 2006;70(11):1437–1442.
   PubMed Web of Science ®Google Scholar
• Araki S, Dobashi K, Yamamoto Y, et al. Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children. Eur J Pediatr. 2010;169(8):965–970.
   PubMed Web of Science ®Google Scholar
• Park K, Gross M, Lee DH, et al. Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care. 2009;32(7):1302–1307.
   PubMed Web of Science ®Google Scholar
• Ihara Y, Toyokuni S, Uchida K, et al. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes. 1999;48(4):927–932.
   PubMed Web of Science ®Google Scholar
• Scherag A, Dina C, Hinney A, et al. Two new loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLoS Genet. 2010;6(4):e1000916.
   PubMed Web of Science ®Google Scholar
• Lindgren CM, Heid IM, Randall JC, et al. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLOS Genet. 2009;5(6):e1000508.
   PubMed Web of Science ®Google Scholar
• Dorajoo R, Blakemore AIF, Sim X, et al. Replication of 13 obesity loci among Singaporean Chinese, Malay and Asian-Indian populations. Int J Obes (Lond). 2012;36(1):159–163.
   PubMed Web of Science ®Google Scholar
• Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35.
   PubMed Web of Science ®Google Scholar
• Brock JWC, Jenkins AJ, Lyons TJ, et al. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J Lipid Res. 2008;49(4):847–855.
   PubMed Web of Science ®Google Scholar
• Uthus EO, Picklo MJ. Obesity reduces methionine sulphoxide reductase activity in visceral adipose tissue. Free Radic Res. 2011;45(9):1052–1060.
   PubMed Web of Science ®Google Scholar
• Styskal J, Nwagwu FA, Watkins YN, et al. Methionine sulfoxide reductase A affects insulin resistance by protecting insulin receptor function. Free Radic Biol Med. 2013;56:123–132.
   PubMed Web of Science ®Google Scholar
• Hunnicut J, Liu Y, Richardson A, et al. MsrA overexpression targeted to the mitochondria, but not cytosol, preserves insulin sensitivity in diet-induced obese mice. PLoS One. 2015;10(10):e0139844.
   PubMed Web of Science ®Google Scholar
• Granot-Hershkovitz E, Karasik D, Friedlander Y, et al. A study of Kibbutzim in Israel reveals risk factors for cardiometabolic traits and subtle population structure. Eur J Hum Genet. 2018;26(12):1848–1858.
   PubMed Web of Science ®Google Scholar
• Schallreuter KU, Salem MM, Hasse S, et al. The redox – biochemistry of human hair pigmentation. Pigment Cell Melanoma Res. 2011;24(1):51–62.
   PubMed Web of Science ®Google Scholar
• Schallreuter KU, Rübsam K, Gibbons NCJ, et al. Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo. J Invest Dermatol. 2008;128(4):808–815.
   PubMed Web of Science ®Google Scholar
• Martín JE, Alizadeh BZ, González-Gay MA, et al. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. Arthritis Rheum. 2010;62(11):3183–3190.
   PubMedGoogle Scholar
• García-Bermúdez M, López-Mejías R, González-Juanatey C, et al. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. Scand J Rheumatol. 2012;41(5):350–353.
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim HY. Methionine sulfoxide reductase A regulates cell growth through the p53-p21 pathway. Biochem Biophys Res Commun. 2011;416(1–2):70–75.
   PubMed Web of Science ®Google Scholar
• Lei KF, Wang YF, Zhu XQ, et al. Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma. BMC Cancer. 2007;7:172.
   PubMed Web of Science ®Google Scholar
• De Luca A, Sanna F, Sallese M, et al. Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype. Proc Natl Acad Sci USA. 2010;107(43):18628–18633.
   PubMed Web of Science ®Google Scholar
• Ahmed ZM, Yousaf R, Lee BC, et al. Functional null mutations of MSRB3 encoding methionine sulfoxide reductase are associated with human deafness DFNB74. Am J Hum Genet. 2011;88(1):19–29.
   PubMed Web of Science ®Google Scholar
• Kwon TJ, Cho HJ, Kim UK, et al. Methionine sulfoxide reductase B3 deficiency causes hearing loss due to stereocilia degeneration and apoptotic cell death in cochlear hair cells. Hum Mol Genet. 2014;23(6):1591–1601.
   PubMed Web of Science ®Google Scholar
• Picot CR, Perichon M, Cintrat JC, et al. The peptide methionine sulfoxide reductases, MsrA and MsrB (hCBS-1), are downregulated during replicative senescence of human WI-38 fibroblasts. FEBS Lett. 2004;558(1–3):74–78.
   PubMed Web of Science ®Google Scholar
• Minniti AN, Cataldo R, Trigo C, et al. Methionine sulfoxide reductase A expression is regulated by the DAF-16/FOXO pathway in Caenorhabditis elegans. Aging Cell. 2009;8(6):690–705.
   PubMed Web of Science ®Google Scholar
• Chung H, Kim AK, Jung SA, et al. The Drosophila homolog of methionine sulfoxide reductase A extends lifespan and increases nuclear localization of FOXO. FEBS Lett. 2010;584(16):3609–3614.
   PubMed Web of Science ®Google Scholar
• Silva-Sena GG, Camporez D, Santos LRD, et al. An association study of FOXO3 variant and longevity. Genet Mol Biol. 2018;41(2):386–396.
   PubMed Web of Science ®Google Scholar
• Reiterer M, Milton S. Mechanisms of neuroprotection against oxidative stress in the anoxia tolerant turtle Trachemys scripta. FASEB J. 2018;32(1_supplement):5449.
   Web of Science ®Google Scholar